CD61 and CD49f can also identify HER2/neu induced breast tumor-initiating cells and regulate the self-renewal of breast cancer-initiating cells through the Integrin-TGFβ signaling, maintaining the stemness of breast tumors (Lo et al., 2012). Here, ERBB2 is linked to breast carcinoma.